NO20004363D0 - Anvendelse av D1-/D5-antagonister for behandling av tvangsforstyrrelser, somatoforme forstyrrelser, dissosiative forstyrrelser, impulskontroll forstyrrelser og autisme - Google Patents

Anvendelse av D1-/D5-antagonister for behandling av tvangsforstyrrelser, somatoforme forstyrrelser, dissosiative forstyrrelser, impulskontroll forstyrrelser og autisme

Info

Publication number
NO20004363D0
NO20004363D0 NO20004363A NO20004363A NO20004363D0 NO 20004363 D0 NO20004363 D0 NO 20004363D0 NO 20004363 A NO20004363 A NO 20004363A NO 20004363 A NO20004363 A NO 20004363A NO 20004363 D0 NO20004363 D0 NO 20004363D0
Authority
NO
Norway
Prior art keywords
disorders
autism
obsessive
antagonists
treatment
Prior art date
Application number
NO20004363A
Other languages
English (en)
Other versions
NO20004363L (no
Inventor
Vicki L Coffin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20004363D0 publication Critical patent/NO20004363D0/no
Publication of NO20004363L publication Critical patent/NO20004363L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
NO20004363A 1998-03-02 2000-09-01 Anvendelse av D1-/D5-antagonister for behandling av tvangsforstyrrelser, somatoforme forstyrrelser, dissosiative forstyrrelser, impulskontrollforstyrrelser og autisme NO20004363L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3320598A 1998-03-02 1998-03-02
PCT/US1999/003721 WO1999044615A1 (en) 1998-03-02 1999-03-01 Use of d1/d5 antagonists for treating obsessive compulsive disorders, somatoform disorders, dissociative, eating disorders, impulse control disorders and autism

Publications (2)

Publication Number Publication Date
NO20004363D0 true NO20004363D0 (no) 2000-09-01
NO20004363L NO20004363L (no) 2000-10-31

Family

ID=21869083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004363A NO20004363L (no) 1998-03-02 2000-09-01 Anvendelse av D1-/D5-antagonister for behandling av tvangsforstyrrelser, somatoforme forstyrrelser, dissosiative forstyrrelser, impulskontrollforstyrrelser og autisme

Country Status (16)

Country Link
EP (1) EP1058551A1 (no)
JP (1) JP2002505291A (no)
KR (1) KR20010041477A (no)
CN (1) CN1291893A (no)
AR (1) AR018297A1 (no)
AU (1) AU2778099A (no)
BR (1) BR9908392A (no)
CA (1) CA2322201A1 (no)
CO (1) CO4910136A1 (no)
HU (1) HUP0101057A3 (no)
IL (1) IL137715A0 (no)
NO (1) NO20004363L (no)
PE (1) PE20000333A1 (no)
SK (1) SK12962000A3 (no)
WO (1) WO1999044615A1 (no)
ZA (1) ZA991638B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
RU2374245C1 (ru) 2008-08-22 2009-11-27 Андрей Александрович Иващенко Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство
US11298361B2 (en) * 2012-07-12 2022-04-12 Emalex Biosciences, Inc. Fused benzazepines for treatment of Tourette's Syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
IL137715A0 (en) 2001-10-31
WO1999044615A1 (en) 1999-09-10
NO20004363L (no) 2000-10-31
EP1058551A1 (en) 2000-12-13
BR9908392A (pt) 2000-10-31
CO4910136A1 (es) 2000-04-24
HUP0101057A3 (en) 2001-09-28
KR20010041477A (ko) 2001-05-25
ZA991638B (en) 1999-09-01
AR018297A1 (es) 2001-11-14
CA2322201A1 (en) 1999-09-10
HUP0101057A2 (hu) 2001-08-28
PE20000333A1 (es) 2000-05-13
AU2778099A (en) 1999-09-20
SK12962000A3 (sk) 2001-08-06
JP2002505291A (ja) 2002-02-19
CN1291893A (zh) 2001-04-18

Similar Documents

Publication Publication Date Title
MXPA03007960A (es) Compuestos y metodos para el tratamiento de desordenes urogenitales.
DK1459750T3 (da) (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
HK1152243A1 (en) Vegf for use in the treatment of central nervous system disorders vegf
MXPA03006010A (es) Derivados de arilamina sustituida y metodos de uso.
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
GB0007193D0 (en) Treatment of movrmrnt disorders
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
HK1053058A1 (zh) 普拉克索用於治療成癮性疾病的用途
NO20032636D0 (no) 3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
NO20030800L (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
HK1041880A1 (en) Compounds and methods for treatment of asthma, allergy and inflammatory disorders.
EP1409015A4 (en) METHODS OF TREATING OR PREVENTING SKIN DISORDERS USING CD2 BINDING AGENTS
ZA200108856B (en) Treatment of neurotic disorders.
NO20010456L (no) Triazolopyridiner for behandling av trombose lidelser
ZA200205098B (en) Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders.
MXPA03004190A (es) Tratamiento de trastornos de ansiedad.
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20004363D0 (no) Anvendelse av D1-/D5-antagonister for behandling av tvangsforstyrrelser, somatoforme forstyrrelser, dissosiative forstyrrelser, impulskontroll forstyrrelser og autisme
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20030717D0 (no) Forbindelser for behandling av avhengighetsforstyrrelser
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20012616L (no) Middel til behandling av erektil malfunksjon